Researchers in New Zealand have found that teenagers given a meningitis B vaccine were significantly less likely to contract gonorrhoea, marking the first time a vaccine has shown any protection against the sexually transmitted infection (STI).
Read More
Pfizer’s new meningitis B vaccine Trumenba is now available in the UK for teens and young adults providing an additional option for vaccination against the disease.
Read More
Pfizer’s Trumenba has been cleared by European regulators to help prevent infection with meningococcal group B disease in adolescents and adults.
Read More
The Department of Health has put out a call for researchers to undertake a national study to assess the effect of the meningitis B vaccine in preventing adolescents from carrying the meningococcal B bacteria.
Read More
GlaxoSmithKline is reporting encouraging rates of efficacy from the world’s first national meningitis B immunisation programme with Bexsero, a year after its UK launch.
Read More
Campaigners for expanding the scope of routine meningitis B vaccination in the UK say they are disappointed with a decision that a programme in infants aged one to two is not feasible.
Read More
